Development of a single-chain fragment variable fused-mutant HALT-1 recombinant immunotoxin against G12V mutated KRAS colorectal cancer cells.
Michelle Yee Mun TeoJeremy Jeack Ceen NgJung Yin FongJung Shan HwangAdelene Ai-Lian SongRenee Lay Hong LimLionel Lian Aun InPublished in: PeerJ (2021)
These results suggested that the development of such immunotoxins is potentially useful as an immunotherapeutic application against KRAS-positive malignancies.
Keyphrases